“…Several studies have investigated the programmatic barriers to optimal uptake of the hepatitis B birth-dose vaccine in Africa, using both quantitative and qualitative research approaches. Some of the barriers reported across the literature include the lack of relevant policies at both national and health-facility levels [73,74], lack of funding or out-of-pocket payment requirements [75], poor monitoring and evaluation systems [73,74], lack of integration with the maternal and child health package [14,74], lack of awareness about HBV infection and hepatitis B birth-dose vaccination among pregnant women [75,76], geographical inaccessibility of immunization clinics [75,77], inaccessibility due to allotted vaccination days [74,75], frequent stockouts [75,78], home births [79,80], lack of outreach services [74], mistrust of HCWs handling newborns [76], birth doses administered on discharge only [74], poor knowledge of contraindications among HCWs, and absence of delineated staff [74]. In 2017, Breakwell et al published a MEDLINE literature review citing (i) timely administration, (ii) the high prevalence of home births, (iii) the lack of services available to reach infants born at home, and (iv) unreliable vaccine supplies as challenges limiting improved adoption and coverage of the hepatitis B birth-dose vaccination program [2].…”